Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 
Region: All Regions > South America
Category: All Categories > Life Sciences > Pharmaceuticals > Manufacturing, Packaging & Detailing
(78 reports matching your criteria)
< prev 1    3  4  
Peru Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... appeal in 2015 as thecountry's burden of chronic diseases and demand for medicines grows. A positive economic outlook forPeru in 2016 will also aid in the positive trajectory of the country's pharmaceutical and healthcaremarkets. Headline ...  |  read more...
USD 1,295
Brazil Pharmaceuticals and Healthcare Report Q3 2015
6/3/2015 | published by: BMI Research
... as the demandfor medical provision as well as access to necessary healthcare improves in the country. Limited drugapprovals and the Ministry of Health's implication within the Petrobras scandal will, however, continue togenerate risks within the ...  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... the healthcareand pharmaceutical markets on positive trajectories. However, the country's expanding counterfeit drugmarket along with government bailouts for local health insurance schemes will remain a risk in 2015. Headline Expenditure Projections Pharmaceuticals: COP8,643bn (USD4.3bn) in ...  |  read more...
USD 1,295
Calming and Sleeping in Peru
5/12/2015 | published by: Euromonitor International
... without consulting a psychiatrist which is surrounded by myths about mental illness. Euromonitor International's Calming and Sleeping in Peru report offers a comprehensive guide to the size and shape of the market at a national ...  |  read more...
USD 990
Argentina Pharmaceuticals and Healthcare Report Q3 2015
5/6/2015 | published by: BMI Research
... in LatinAmerica. Combined with expected improvements in the Argentinean business environment to take placewith the next government administration since 2016, risks to our pharmaceuticals and healthcare forecastsare weighted to the upside. However, we expect a ...  |  read more...
USD 1,295
Venezuela Pharmaceuticals and Healthcare Report Q2 2015
4/8/2015 | published by: BMI Research
... one of theworst performing currencies in the world, multinational pharmaceutical companies will be further deterredfrom continued activity in Venezuela throughout 2015, despite the country's continued attempts to manageits severe drug supply and weakening health system. ...  |  read more...
USD 1,295
Brazil Pharmaceuticals and Healthcare Report Q2 2015
4/1/2015 | published by: BMI Research
... America. However, low affordability and increasing generic drug competition willhamper opportunities for innovative drugmakers as the country continues to develop its economy. Headline Expenditure Projections Pharmaceuticals: BRL62.0bn (USD26.3bn) in 2014 to BRL65.3bn (USD25.6bn) in 2015; ...  |  read more...
USD 1,295
Chile Pharmaceuticals and Healthcare Report Q2 2015
3/11/2015 | published by: BMI Research
... and rising incidence of chronic, non-communicable disease support greater demand forpharmaceuticals. Notably, the government's apparent commitment to market-friendly policy-making andreliance on imported prescription treatments will see quickly growing pharmaceutical sales occur within aconstantly improving operating ...  |  read more...
USD 1,295
Latin American Contract Research Organization Market
3/10/2015 | published by: Frost & Sullivan
... 2016, behind the United States, China, and Japan. The main drivers for market growth are generic drugs manufactured by local pharmaceutical companies and biosimilars manufactured both by multinational and local pharmaceutical companies. In 2013, the ...  |  read more...
USD 6,000
Peru Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... while thepharmaceutical and healthcare markets continue to grow, the national economy continues to struggle andits dependence on key exports will hamper overall growth in the short-term. Headline Expenditure Projections Pharmaceuticals: PEN4.7bn (USD1.65bn) in 2014 to ...  |  read more...
USD 1,295
Brazilian Pharmaceutical Market Outlook 2015-2025
2/18/2015 | published by: Visiongain
... study gives you multilevel revenue forecasts, helping your research and analysis. That report’s purpose is showing results, opportunities and future business trends. Brazil can satisfy expectations for expanding healthcare coverage and rapid growth of its ...  |  read more...
USD 2,788
Venezuela Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: BMI Research
... of local medicines in the near term. However, fundamental issues - such as price controls, highinflation, currency devaluation, import and foreign currency controls and the government's attitude towardsnormal business practices - have not changed. We ...  |  read more...
USD 1,295
Chemical & Pharmaceutical Plant Construction in Colombia to 2018: Market Databook
10/22/2014 | published by: Timetric
... chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the ...  |  read more...
USD 500
Pharmaceuticals and Healthcare Report - Chile Q4 2014
10/15/2014 | published by: BMI Research
... drugmakers' strongLatin American presence will continue to attract multinational investment in the country. Headline Expenditure Projections Pharmaceuticals: CLP1,724bn (USD3.5bn) in 2013 to CLP1,849bn (USD3.29bn) in 2014; +7.3% inlocal currency terms and -5.4% in US dollar ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Argentina Q4 2014
8/27/2014 | published by: BMI Research
... erode the growth ofthe country's pharmaceutical market. More foreign pharmaceutical companies will cease their localoperations, if the hostile business environment is worsened. Headline Expenditure Projections Pharmaceuticals: ARS39.30bn (USD7.18 bn) in 2013 to ARS50.10bn (USD6.04bn) in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Colombia Q4 2014
8/27/2014 | published by: BMI Research
... bioequivalence regulationswill also undermine sale growth posted by branded generic drugmakers. However, Colombia's relativelyadvanced drug reimbursement system will still offer revenue-generating opportunities for multinationals incomparison with other second-tier Latin American pharmaceutical markets. Headline Expenditure Projections ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Venezuela Q3 2014
7/11/2014 | published by: BMI Research
... market until the end of President Maduro's first term. Headline Expenditure Projections Pharmaceuticals: VEB59.85bn (USD9.85bn) in 2013 to VEB88.73bn (USD10.09bn) in 2014; +48.2%in local currency terms and 2.4% in US dollar terms. Forecast revised upwards ...  |  read more...
USD 1,295
Uruguay Analgesics
6/12/2014 | published by: Euromonitor International
... report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2009-2013, allowing you to identify the sectors driving growth. Forecasts to ...  |  read more...
USD 900
Pharmaceuticals and Healthcare : Brazil Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: BMI Research
... improving regulatory regimeand significant private healthcare growth mean that the market presents significant revenue-generatingopportunities for drugmakers and healthcare service providers. However, multinationals will continue toface increasing drug pricing pressure and domestic competition. Headline Expenditure Projections ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Peru Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: BMI Research
... the country due to the lack of a mandatorymedicine pricing system in the country. More stringent quality control, a relatively weak domesticpharmaceutical industry, the ongoing liberalisation of bilateral trade agreements and the healthcare reformas well ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Argentina Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: BMI Research
... in the pharmaceutical industry. The localpharmaceutical market and healthcare system will continue to deteriorate due to insufficient medicinesupply. Domestic inflation in Argentina will continue to erode the competitiveness of its pharmaceuticalexports, minimising gains from a ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Colombia Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: BMI Research
... cuts. Less stringent bioequivalence regulationswill also undermine sale growth posted by branded generic drugmakers. However, Colombia's relativelyadvanced drug reimbursement system will still offer revenue-generating opportunities for multinationals incomparison with other second-tier Latin American pharmaceutical markets. ...  |  read more...
USD 1,295
Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry Guide
5/9/2014 | published by: MarketLine
... descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market. Features and benefits Save time carrying out entry-level research by identifying the size, growth, and leading players in ...  |  read more...
USD 995
The Pharmaceutical Market: Brazil
3/11/2014 | published by: Espicom Healthcare Intelligence
... innovative, high-tech products. The government i s increasing ly invest ing in the healthcare sector and pharmaceutical industry to reduce the financial burden of diseases , and the country's private healthcare sectors provide opportunities for ...  |  read more...
USD 1,295
PharmaSphere: Pharmaceutical and Healthcare Deal Trends in Latin America: 2008 - 2012
1/31/2014 | published by: GlobalData
... that took place in the region during the last decade. The type of deals covered in the report include Mergers & Acquisitions (M&A), Licensing and Collaboration & Partnerships. The report also provides understanding on the ...  |  read more...
USD 2,995
< prev 1    3  4